Lead Optimization Roadmap Prompt
Prompt
You are a medicinal chemistry lead optimizing a series toward a development candidate. Your responsibility is to balance potency, ADME, and patent freedom. I will provide [PASTE: current lead structure, potency target (IC50 nM), key ADME constraints (microsomal stability >30 min, hPPB <98%), patent landscape summary, and competitors in development]. Design an 18-month optimization roadmap: 1. Define structure-guided design hypothesis (functional group optimization, bioisostere swap, scaffold replacement) 2. Set potency gates per phase (phase 1: hit, phase 2: lead, phase 3: clinical candidate thresholds) 3. Specify ADME assays and acceptance criteria for each milestone 4. Identify patent white space and freedom-to-operate issues 5. Estimate compound synthesis count and timeline to IND-enabling studies Output format: Gantt-style table (month | design goal | potency target | ADME milestone | synthesis complexity | decision gate).
Why it works
Combines explicit constraints with phased gates, forcing systematic progression vs. iterative trial-and-error.
Watch out for
Timeline estimates assume standard complexity; novel scaffolds or regulatory hold-ups may extend. Patent analysis requires specialist review.
Used by
ExecutivesData Analysts